Thereby, we demonstrated that vascular endothelial grow factor (VEGF), hypoxia-inducible factor 1-alpha (HIF), and fibronectin (FN1) expression were differentially over-expressed in low- risk MDS patients, including RCMD cases. This evidence concerns the gene HIF1A and myelodysplastic syndrome with multilineage dysplasia.